Shigeru Tsukagoshi

6.3k total citations · 3 hit papers
144 papers, 5.4k citations indexed

About

Shigeru Tsukagoshi is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Shigeru Tsukagoshi has authored 144 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Oncology, 55 papers in Molecular Biology and 34 papers in Organic Chemistry. Recurrent topics in Shigeru Tsukagoshi's work include Cancer Treatment and Pharmacology (31 papers), Cancer therapeutics and mechanisms (21 papers) and Synthesis and biological activity (12 papers). Shigeru Tsukagoshi is often cited by papers focused on Cancer Treatment and Pharmacology (31 papers), Cancer therapeutics and mechanisms (21 papers) and Synthesis and biological activity (12 papers). Shigeru Tsukagoshi collaborates with scholars based in Japan, United States and India. Shigeru Tsukagoshi's co-authors include Yoshio Sakurai, Takashi Tsuruo, Harumi Iida, Makiko Nojiri, Takao Yamori, Makoto Inaba, Tazuko Tashiro, Tateshi Kataoka, Tomowo Kobayashi and Hironori Kawabata and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Gastroenterology.

In The Last Decade

Shigeru Tsukagoshi

141 papers receiving 5.0k citations

Hit Papers

Overcoming of vincristine resistance in P388 leukemia in ... 1981 2026 1996 2011 1981 1982 1983 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.
    1981 1.3k citations Takashi Tsuruo, Harumi Iida et al. PubMed profile →
  2. Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.
    1982 598 citations Takashi Tsuruo, Harumi Iida et al. PubMed profile →
  3. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    1983 337 citations Takashi Tsuruo, Harumi Iida et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shigeru Tsukagoshi Japan 32 3.0k 2.7k 759 584 561 144 5.4k
William T. Beck United States 50 4.2k 1.4× 5.3k 1.9× 560 0.7× 605 1.0× 542 1.0× 131 7.4k
Kees Nooter Netherlands 52 5.4k 1.8× 3.9k 1.4× 428 0.6× 960 1.6× 609 1.1× 149 9.1k
Ahmad R. Safa United States 43 3.8k 1.3× 3.8k 1.4× 252 0.3× 720 1.2× 577 1.0× 130 6.1k
Harumi Iida Japan 20 2.5k 0.8× 1.9k 0.7× 293 0.4× 560 1.0× 465 0.8× 33 3.5k
Peter Charlton United Kingdom 34 2.1k 0.7× 2.7k 1.0× 602 0.8× 452 0.8× 346 0.6× 74 4.5k
T Tsuruo Japan 49 5.6k 1.9× 5.4k 2.0× 508 0.7× 1.3k 2.3× 796 1.4× 155 9.7k
Christine A. Hrycyna United States 37 3.7k 1.2× 3.4k 1.2× 327 0.4× 1.3k 2.1× 1.0k 1.8× 82 6.5k
James M. Gallo United States 42 1.3k 0.4× 1.9k 0.7× 322 0.4× 329 0.6× 348 0.6× 154 5.0k
Kenneth K.W. To Hong Kong 48 3.2k 1.1× 4.0k 1.5× 508 0.7× 394 0.7× 388 0.7× 164 7.5k
Suneet Shukla United States 41 3.4k 1.1× 2.3k 0.9× 321 0.4× 728 1.2× 902 1.6× 77 5.1k

Countries citing papers authored by Shigeru Tsukagoshi

Since Specialization
Citations

This map shows the geographic impact of Shigeru Tsukagoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Tsukagoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Tsukagoshi more than expected).

Fields of papers citing papers by Shigeru Tsukagoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Tsukagoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Tsukagoshi. The network helps show where Shigeru Tsukagoshi may publish in the future.

Co-authorship network of co-authors of Shigeru Tsukagoshi

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Tsukagoshi. A scholar is included among the top collaborators of Shigeru Tsukagoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Tsukagoshi. Shigeru Tsukagoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsukagoshi, Shigeru, N Horikoshi, Shunji Takahashi, et al.. (1996). A novel transdermal preparation of morphine and possibility of the clinical application for cancer pain.. Drug Delivery System. 11(6). 393–397. 1 indexed citations
2.
Miyazaki, Koichi, et al.. (1995). Synthesis and Antitumor Activity of Novel Dolastatin 10 Analogs.. Chemical and Pharmaceutical Bulletin. 43(10). 1706–1718. 88 indexed citations
3.
Iwai, Masakazu, et al.. (1995). Antimicrotubule effects of the novel antitumor benzoylphenylurea derivative HO-221. Cancer Chemotherapy and Pharmacology. 37(1-2). 63–69. 12 indexed citations
4.
Tashiro, Tazuko, et al.. (1994). Antitumor effects of IST-622, a novel synthetic derivative of chartreusin, against murine and human tumor lines following oral administration. Cancer Chemotherapy and Pharmacology. 34(4). 287–292. 13 indexed citations
5.
Yang, De, Motonobu Satoh, Hiroshi Ueda, Shigeru Tsukagoshi, & Masatoshi Yamazaki. (1994). Activation of tumor-infiltrating macrophages by a synthetic lipid A analog (ONO-4007) and its implication in antitumor effects. Cancer Immunology Immunotherapy. 38(5). 287–293. 38 indexed citations
6.
Nagao, Yoshimitsu, et al.. (1992). Different Mechanisms of Action of Long Chain Fatty Acid Esters of Podophyllotoxin and Esters of Epipodophyllotoxin against P388 Lymphocytic Leukemia in Mice.. 41. 56. 1 indexed citations
7.
Nakae, Takashi, et al.. (1991). Intracellular behavior of ad nycin-oxidized dextran conjugate.. Drug Delivery System. 6(2). 127–131. 4 indexed citations
8.
Tomioka, Kiyoshi, Taro Ishiguro, Hiroshi Mizuguchi, et al.. (1991). Stereoselective reactions. XVII. Absolute structure-cytotoxic activity relationships of steganacin congeners and analogs. Journal of Medicinal Chemistry. 34(1). 54–57. 38 indexed citations
9.
Narita, Toshiharu, Yuji Koide, Shin‐ichi Yaguchi, et al.. (1991). Antitumor activities and schedule dependence of orally administered MST-16, a novel derivative of bis(2,6-dioxopiperazine). Cancer Chemotherapy and Pharmacology. 28(4). 235–240. 19 indexed citations
10.
Ueda, Yasuo, et al.. (1990). Tissue concentration of adriamycin and adriamycinoxidized dextran conjugate in tumor bearing rats and mice.. Drug Delivery System. 5(4). 255–260. 7 indexed citations
11.
Amagase, Harunobu, et al.. (1990). Epidermal Growth Factor Prolongs Survival Time of Tumor‐bearing Mice. Japanese Journal of Cancer Research. 81(5). 495–500. 3 indexed citations
12.
Narita, Toshiharu, Shin‐ichi Yaguchi, Toshihiko Komatsu, et al.. (1990). Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models. Cancer Chemotherapy and Pharmacology. 26(3). 193–197. 17 indexed citations
13.
Ishii, Yoshiaki & Shigeru Tsukagoshi. (1989). The synergistic effect of human recombinant interferon-.ALPHA.2a in combination with interferon-.GAMMA. and the induction of interferon-.ALPHA.2a receptor by interferon-.GAMMA... Journal of Pharmacobio-Dynamics. 12(5). 299–304. 11 indexed citations
14.
Yamori, Takao, Harumi Iida, Shigeru Tsukagoshi, & Takashi Tsuruo. (1988). Growth stimulating activity of lung extract on lung-colonizing colon 26 clones and its partial characterization. Clinical & Experimental Metastasis. 6(2). 131–139. 27 indexed citations
15.
Kawahara, Kazuo, et al.. (1987). A novel antitumor cyclic hexapeptide (RA-700) obtained from Rubiae Radix.. Journal of Pharmacobio-Dynamics. 10(11). 616–623. 10 indexed citations
16.
Yamato, Masatoshi, Kuniko Hashigaki, Richard F. Ludueña, et al.. (1987). Synthesis and antitumor activity of tropolone derivatives. 6. Structure-activity relationships of antitumor-active tropolone and 8-hydroxyquinoline derivatives. Journal of Medicinal Chemistry. 30(10). 1897–1900. 41 indexed citations
17.
Kidani, Yoshinori, Masahide Noji, Shigeru Tsukagoshi, & Tazuko Tashiro. (1978). Antitumor activity of water-soluble platinum(II) complexes of 1,2-cyclohexanediamine isomers.. PubMed. 69(2). 263–5. 4 indexed citations
18.
Oh-hashi, Fujiko, Tateshi Kataoka, & Shigeru Tsukagoshi. (1978). Effect of combined use of anticancer drugs with a polysaccharide preparation, Krestin, on mouse leukemia P388.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 69(2). 255–7. 10 indexed citations
19.
Tsukagoshi, Shigeru, et al.. (1977). N4-Behenoyl-1-beta-D-arabinofuranosylcytosine as a potential new antitumor agent.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 37(8 Pt 1). 2481–6. 54 indexed citations
20.
Kataoka, Tateshi, Shigeru Tsukagoshi, & Yoshio Sakurai. (1975). Transplantability of L1210 Cell in BALB/c × DBA/2F1 Mice Associated with Cell Agglutinability by Concanavalin A. Cancer Research. 35(3). 531–534. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William T. Beck Breakdown of academic impact, for papers by Kees Nooter Breakdown of academic impact, for papers by Ahmad R. Safa Breakdown of academic impact, for papers by Harumi Iida Breakdown of academic impact, for papers by Peter Charlton Breakdown of academic impact, for papers by T Tsuruo Breakdown of academic impact, for papers by Christine A. Hrycyna Breakdown of academic impact, for papers by James M. Gallo Breakdown of academic impact, for papers by Kenneth K.W. To Breakdown of academic impact, for papers by Suneet Shukla
Rankless by CCL
2026